In this podcast, 4 experts discuss the first-ever targeted therapies approved for people with non-small cell lung cancer with an epidermal growth factor receptor (EGFR) exon 20 insertion mutation, including how they work and what they mean for people with this type of cancer. Read More >>
lung cancer
December 16, 2021 · Brielle Gregory Collins, ASCO staff
August 5, 2021 · Brielle Gregory Collins, ASCO staff
In this podcast, Cancer.Net Associate Editors discuss new research presented at the 2021 ASCO Annual Meeting in lung cancer, breast cancer, and sarcoma and describe what this research means for people with cancer. Read More >>
June 8, 2021 · Jyoti Patel, MD, FASCO
In Dr. Jyoti Patel’s first "From the Editor in Chief" post, she discusses what got her interested in caring for people with cancer, how she’s seen Cancer.Net evolve over the years, and what her goals are for the future of the site. Read More >>
May 19, 2021 · ASCO Staff
Lea los puntos destacados de la investigación temprana que acaban de publicar para la reunión anual de la American Society of Clinical Oncology (Sociedad Americana de Oncología Clínica) de 2021. Los temas incluyen la inmunoterapia para el melanoma y el cáncer de pulmón de no microcítico (NSCLC, por sus siglas en inglés), la detección del antígeno prostático específico (PSA, por sus siglas en inglés) para el cáncer de próstata, la vacunación contra el VPH y los límites de elegibilidad de los ingresos de Medicaid. Read More >>
May 19, 2021 · ASCO Staff
Read early research highlights just released for the 2021 ASCO Annual Meeting. Topics include immunotherapy for melanoma and non-small cell lung cancer, PSA screening for prostate cancer, HPV vaccination, and Medicaid income eligibility limits. Read More >>